Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02535078
Title Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Immunocore Ltd
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field